Development and validation of a bioanalytical LC-UV method with solid-phase extraction for determination of valproic acid in saliva

P. Loiseau, Rational use of valproate: Indications and drug regimen in epilepsy, Epilepsy 25 (1984) 65-72; DOI: 10.1111/j.1528-1157.1984.tb05641.x.10.1111/j.1528-1157.1984.tb05641.xSearch in Google Scholar

O. Dulac, D. Steru, E. Rey and M. Arthius, Sodium valproate monotherapy in childhood epilepsy, Brain Dev. 8 (1986) 47-52.10.1016/S0387-7604(86)80119-XSearch in Google Scholar

D. C. Lagacea, W. T. O'Brienb, N. Gurvichb, M. W. Nachtigala and P. S. Klein, Valproic acid: How it works. Or not, Clin. Neurosci. Res. 4 (2004) 215-225; DOI: 10.1016/j.cnr.2004.09.013.10.1016/j.cnr.2004.09.013Search in Google Scholar

P. Wal, B. Kumar, A. Bhandari, A. K. Rai and A. Wal, Bioanalytical method development - Determination of drugs in biological fluids, J. Pharm. Sci. Tech. 2 (2010) 333-347.Search in Google Scholar

S. I. Johannessen, Therapeutic Drug Monitoring of Antiepileptic Drugs, in Drug Monitoring and Clinical Chemistry (Ed. G. Hempel) in Elsevier, Amsterdan 2004, in (Ed. R. M. Smith) Handbook of Analytical Separation. Vol. 5, pp. 221-253; DOI: 10.1016/S1567-7192(04)80010-X.10.1016/S1567-7192(04)80010-XSearch in Google Scholar

P. N. Patsalos, D. J. Berry, B. F. D. Bourgeois, J. C. Cloyd, T. A. Glauser, S. I. Johannessen, I. E. Leppik, T. Tomson and E. P. Patsalos, Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on the therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies, Epilepsia (2008) 1-38; DOI: 10.1111/j.1528-1167.2008.01561.x.10.1111/j.1528-1167.2008.01561.xSearch in Google Scholar

S. J. Soldin, Free drug measurement, Arch. Pathol. Lab. Med. 123 (1999) 822-823.10.5858/1999-123-0822-FDMSearch in Google Scholar

H. Liu and M. R. Delgado, Therapeutic drug concentration monitoring using saliva samples, Clin. Pharmacokin. 36 (1999) 453-470; DOI: 10.2165/00003088-199936060-00006.10.2165/00003088-199936060-00006Search in Google Scholar

H. S. Chung, T. L. Seung and L. Soo-Youn, Evaluation of Viva-E drug testing system, Korean J. Lab. Med. 27 (2007) 330-337; DOI: 10.3343/kjlm.2007.27.5.330.10.3343/kjlm.2007.27.5.330Search in Google Scholar

R. L. Dills and D. D. Shen, Methods to reduce background interferences in electron-capture gas chromathographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromide, J. Chromatogr. B Biomed. Appl. 690 (1997) 139-152; DOI: 10.1016/S0378-4347(96)00405-7.10.1016/S0378-4347(96)00405-7Search in Google Scholar

S. Rompotis, M. Parissi-Poulou, E. Gikas, M. Kazanis, A. Vavayannis and I. Panderi, Determination of valproic acid in human plasma by HPLC with fluorescence detection, J. Liq. Chromatogr. 25 (2002) 2833-2847; DOI: 10.1081/JLC-120014953.10.1081/JLC-120014953Search in Google Scholar

H. Amini, M. Javan and A. Ahmadiani, Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization, J. Chromatogr. B 830 (2006) 368-371; DOI: 10.1016/j.jchromb.2005.11.028.10.1016/j.jchromb.2005.11.02816324890Search in Google Scholar

D. S. Jain, G. Subbaiah, M. Sanyal and P. Shrivastav, A high through and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS/MS, Talanta 72 (2007) 80-88.10.1016/j.talanta.2006.09.03319071585Search in Google Scholar

Guideline on validation of bioanalytical methods, European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), London 2009; http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500018062.pdfSearch in Google Scholar

M. Krogh, K. Johansen, F. Tonnesen and K. E. Rasmussen, Solid-phase microextraction for the determination of the free concentration of valproic acid in human plasma by capillary gas chromatography, J. Chromatogr. B 673 (1995) 299-305; DOI: 10.1016/03784347(95)00273-8.Search in Google Scholar